Lilly, Merck expand oncology clinical trial collaboration

[EGBOT]

Lilly, Merck expand oncology clinical trial collaboration

Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced the extension of an existing collaboration to evaluate the safety and efficacy of the combination of Lilly's ALIMTA (pemetrexed for injection) and Merck's KEYTRUDA (pembrolizumab) in a pivotal Phase III study in first-line nonsquamous non-small cell lung cancer (NSCLC).

Source: Lilly, Merck expand oncology clinical trial collaboration

 

[Hogslayer]

Yes I read that it's a fascinating study. Waters muddy though.